Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 16, 2022
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes
Roopa Mehta, Liana K Billings, Andreas Liebl, et al.
Clinical Medicine Insights. Endocrinology and Diabetes
|
April 11, 2015
Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review
Andreas Liebl, Kamlesh Khunti, Domingo Orozco-Beltran, et al.
Drugs in R&D
|
February 23, 2018
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
Andreas Liebl, Viswanathan Mohan, Wenying Yang, et al.
Diabetes, Obesity & Metabolism
|
August 19, 2007
Premixed insulin treatment for type 2 diabetes: analogue or human?
Alan J Garber, Robert Ligthelm, Jens S Christiansen, et al.
Diabetes Research and Clinical Practice
|
January 7, 2017
Exploring the characteristics of suboptimally controlled patients after 24weeks of basal insulin treatment: An individualized approach to intensification
Kamlesh Khunti, Taner Damci, Lise Lotte Husemoen, et al.
Noise & Health
|
April 28, 2015
The impact of road traffic noise on cognitive performance in attention-based tasks depends on noise level even within moderate-level ranges
Sabine J Schlittmeier, Alexandra Feil, Andreas Liebl, et al.
Journal of Diabetes Science and Technology
|
June 15, 2019
New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion
Cosima Rieger, Klaus Kurz, Wiebke Mueller-Hoffmann, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 17, 2021
Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study)
William H Polonsky, Riya Arora, Mads Faurby, et al.
Pharmacoeconomics
|
June 28, 2006
Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany
Arran T Shearer, Adrian Bagust, Andreas Liebl, et al.
Applied Ergonomics
|
August 2, 2011
Combined effects of acoustic and visual distraction on cognitive performance and well-being
Andreas Liebl, Jörg Haller, Bernd Jödicke, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 16, 2022
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes
Roopa Mehta, Liana K Billings, Andreas Liebl, et al.
Clinical Medicine Insights. Endocrinology and Diabetes
|
April 11, 2015
Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review
Andreas Liebl, Kamlesh Khunti, Domingo Orozco-Beltran, et al.
Drugs in R&D
|
February 23, 2018
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
Andreas Liebl, Viswanathan Mohan, Wenying Yang, et al.
Diabetes, Obesity & Metabolism
|
August 19, 2007
Premixed insulin treatment for type 2 diabetes: analogue or human?
Alan J Garber, Robert Ligthelm, Jens S Christiansen, et al.
Diabetes Research and Clinical Practice
|
January 7, 2017
Exploring the characteristics of suboptimally controlled patients after 24weeks of basal insulin treatment: An individualized approach to intensification
Kamlesh Khunti, Taner Damci, Lise Lotte Husemoen, et al.
Noise & Health
|
April 28, 2015
The impact of road traffic noise on cognitive performance in attention-based tasks depends on noise level even within moderate-level ranges
Sabine J Schlittmeier, Alexandra Feil, Andreas Liebl, et al.
Journal of Diabetes Science and Technology
|
June 15, 2019
New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion
Cosima Rieger, Klaus Kurz, Wiebke Mueller-Hoffmann, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 17, 2021
Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study)
William H Polonsky, Riya Arora, Mads Faurby, et al.
Pharmacoeconomics
|
June 28, 2006
Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany
Arran T Shearer, Adrian Bagust, Andreas Liebl, et al.
Applied Ergonomics
|
August 2, 2011
Combined effects of acoustic and visual distraction on cognitive performance and well-being
Andreas Liebl, Jörg Haller, Bernd Jödicke, et al.
Page
of 5